fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 6 Sep 2026

NIACL, full dossier

The New India Assurance Company stock is likely to surpass its prior high of ₹382.20 and appreciate to ₹420 within two years from now.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

The New India Assurance Company stock is likely to surpass its prior high of ₹382.20 and appreciate to ₹420 within two years from now.

thehindubusinessline.com6 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

New India Assurance Company

₹160.21

▼ -4.08%

Close (EOD), as of 1 Oct 2026 · source

New India Assurance Company: results, dividends, orders, the full cited record →

More on New India Assurance Company

New India Assurance Company slipped lower at market open on Tuesday September 8.

9 Sep 2026 · 1 publisher

New India Assurance Company Ltd lost 10.68% to Rs 206.5 at 14:45 IST and was the biggest loser in the BSE's 'A' group.

9 Sep 2026 · 1 publisher

Shares of New India Assurance Company Ltd. (NIACL) surged to their 52-week high on Monday, September 7, as expectations around the National Stock Exchange (NSE) IPO intensified.

7 Sep 2026 · 1 publisher

New India Assurance Company's share price hit a 52-week high of ₹229.30, surging 17 per cent on the BSE on the back of a six-fold jump in trading volume.

6 Sep 2026 · 1 publisher

Shares of New India Assurance Company gained as much as 19.5% to hit an intraday high of ₹232.74 apiece on Friday, September 4.

5 Sep 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.